Strategic Initiative

Slingshot members are tracking this corporate initiative:

Lilly (LLY) and Merck (MRK) Expand Existing Oncology Collaboration, Agree to Evaluating Lartruvo + Keytruda in Advanced/Metastatic Soft Tissue Sarcoma

Source Link:: http://www.prnewswire.com/news-releases/lilly-and-merck-expand-immuno-oncology-collaboration-300389109.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

MRK

100%

LLY

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Jan 11, 2017

Projected Implementation:

Q1, 2017

Relevance Tracked Until:

Q1, 2019

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords Collaboration, Lartruvo, Keytuda, Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma